Market Tracker

10/24 6:05pm ET

Redhill Biopharma Ltd (NASDAQ:RDHL)

9.60
Data as of Oct 24
 -0.29 / -2.93%
Today’s Change
8.50
Today|||52-Week Range
21.00
-18.64%
Year-to-Date
No recent news for Redhill Biopharma Ltd.

Today’s Trading

Previous close9.89
Today’s open9.83
Day’s range9.60 - 9.83
Volume612
Average volume (3 months)6,011
Market cap$84.4M
Dividend yield--
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)+14.73%
Earnings growth (this year)+31.76%
Earnings growth (next 5 years)--
Revenue growth (last year)-24.76%
P/E ratio--
Price/Sales6,117.05
Price/Book7.04

Competitors

 Today’s
change
Today’s
% change
BOTABiota Pharmaceutical...-0.01-0.41%
CPIXCumberland Pharmaceu...0.000.00%
NERVMinerva Neuroscience...+0.04+0.91%
IMMYImprimis Pharmaceuti...+0.61+7.39%
Data as of 3:59pm ET, 10/24/2014

Financials

Next reporting dateNovember 11, 2014
EPS forecast (this quarter)-$0.50
Annual revenue (last year)$12.0K
Annual profit (last year)-$10.7M
Net profit margin-88,566.67%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Dror Ben-Asher
Director, Deputy CEO-Finance &
Operations
Ori Shilo
Corporate headquarters
Tel Aviv, --

Forecasts